ARTICLE | Company News

AMR Centre, Skolkovo targeting antimicrobial resistance

December 14, 2017 6:11 PM UTC

The Antimicrobial Resistance Centre (Macclesfield, U.K.) and the Skolkovo Foundation (Moscow, Russia) announced a collaboration to identify and fund preclinical projects in Russia to develop therapies and diagnostics to combat antimicrobial resistance.

The AMR Centre will assist Skolkovo-backed small and medium enterprises as they submit applications for international funding, including from the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). Launched in 2016, CARB-X invests in therapeutics, vaccines and devices as they move toward clinical testing. The initiative is funded by the AMR Centre, the Wellcome Trust (London, U.K.) and the U.S. government through HHS's Biomedical Advanced Research and Development Authority (BARDA) (see BioCentury Innovations, Oct. 6, 2016)...